New research from the University of California San Francisco suggests how non-invasive breath tests could predict a patient’s likelihood of developing lung cancer. Dr. Daya Upadhyay, Medical Director of the Lung Nodule Program at UCSF, presented her findings at the...
Thank you all for visiting our booth at the American Thoracic Society International Conference 2015 in Denver last month. It was great to see you and learn more about your specific research interests. Three trends became evident from our conversations and a review...
Exhaled breath as a matrix for biomarker measurement is a relatively new idea. The pace of research has accelerated since 2001 with most of the emphasis on compounds in breath condensate and Volatile Organic Compounds (VOC) in gas-phase breath. Compounds in breath...
Rapid screening and diagnosis of active respiratory infections has emerged as a critical unmet need in improving patient outcomes and preserving public health. Hospitals need to know which infectious organisms are being carried in by new patients so that proper...
Exhaled Breath Condensate pH is one of the most validated biomarkers in EBC. There are many publications linking low EBC pH to various lung diseases and offering reasons to consider pH as part of an exhaled biomarker study. We won’t be exploring the “why” here; just...
Many of the researchers we speak with are interested in collecting cytokines in EBC. While there are many published studies on this topic, it is difficult to conclude the best way to obtain useful cytokine data. What seems to produce excellent results for one research...
